Thomas J. Spencer
#122,351
Most Influential Person Now
Thomas J. Spencer's AcademicInfluence.com Rankings
Download Badge
Biology
Why Is Thomas J. Spencer Influential?
(Suggest an Edit or Addition)Thomas J. Spencer's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Patterns of psychiatric comorbidity, cognition, and psychosocial functioning in adults with attention deficit hyperactivity disorder. (1993) (936)
- Influence of gender on attention deficit hyperactivity disorder in children referred to a psychiatric clinic. (2002) (845)
- Young adult outcome of attention deficit hyperactivity disorder: a controlled 10-year follow-up study (2006) (830)
- Pharmacotherapy of attention-deficit hyperactivity disorder across the life cycle. (1996) (818)
- A prospective 4-year follow-up study of attention-deficit hyperactivity and related disorders. (1996) (755)
- Attention-deficit/hyperactivity disorder: diagnosis, lifespan, comorbidities, and neurobiology. (2007) (695)
- Dopamine transporter density in patients with attention deficit hyperactivity disorder (1999) (672)
- Validity of the World Health Organization Adult ADHD Self‐Report Scale (ASRS) Screener in a representative sample of health plan members (2007) (661)
- Atomoxetine in the treatment of children and adolescents with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, dose-response study. (2001) (635)
- Atomoxetine in adults with ADHD: two randomized, placebo-controlled studies (2003) (575)
- Functional impairments in adults with self-reports of diagnosed ADHD: A controlled study of 1001 adults in the community. (2006) (555)
- Validity of pilot Adult ADHD Self- Report Scale (ASRS) to Rate Adult ADHD symptoms. (2006) (541)
- Psychoactive substance use disorders in adults with attention deficit hyperactivity disorder (ADHD): effects of ADHD and psychiatric comorbidity. (1995) (538)
- Predictors of persistence and remission of ADHD into adolescence: results from a four-year prospective follow-up study. (1996) (508)
- Attention-deficit/hyperactivity disorder (adhd) as a noradrenergic disorder (1999) (469)
- Attention-deficit/hyperactivity disorder in adults: an overview (2000) (425)
- Psychiatric comorbidity and functioning in clinically referred preschool children and school-age youths with ADHD. (2002) (402)
- Clinical correlates of ADHD in females: findings from a large group of girls ascertained from pediatric and psychiatric referral sources. (1999) (389)
- Pharmacotherapy of Attention-deficit/Hyperactivity Disorder Reduces Risk for Substance Use Disorder (1999) (387)
- A double-blind, crossover comparison of methylphenidate and placebo in adults with childhood-onset attention-deficit hyperactivity disorder. (1995) (387)
- Meta-Analysis of the Efficacy of Methylphenidate for Treating Adult Attention-Deficit/Hyperactivity Disorder (2004) (374)
- A large, double-blind, randomized clinical trial of methylphenidate in the treatment of adults with attention-deficit/hyperactivity disorder (2005) (357)
- Which SSRI? A meta-analysis of pharmacotherapy trials in pediatric obsessive-compulsive disorder. (2003) (347)
- Intellectual performance and school failure in children with attention deficit hyperactivity disorder and in their siblings. (1993) (339)
- Results from 2 proof-of-concept, placebo-controlled studies of atomoxetine in children with attention-deficit/hyperactivity disorder. (2002) (335)
- Diagnosing adult attention deficit hyperactivity disorder: are late onset and subthreshold diagnoses valid? (2006) (327)
- Effectiveness and tolerability of tomoxetine in adults with attention deficit hyperactivity disorder. (1998) (319)
- Attention deficit/hyperactivity disorder across the lifespan. (2002) (318)
- Attention-deficit hyperactivity disorder with bipolar disorder: a familial subtype? (1997) (313)
- In Vivo Neuroreceptor Imaging in Attention-Deficit/Hyperactivity Disorder: A Focus on The Dopamine Transporter (2005) (309)
- Does attention-deficit hyperactivity disorder impact the developmental course of drug and alcohol abuse and dependence? (1998) (308)
- Gender differences in a sample of adults with attention deficit hyperactivity disorder (1994) (304)
- Attention deficit hyperactivity disorder (ADHD) is associated with early onset substance use disorders. (1997) (303)
- Modafinil Occupies Dopamine and Norepinephrine Transporters in Vivo and Modulates the Transporters and Trace Amine Activity in Vitro (2006) (299)
- High risk for attention deficit hyperactivity disorder among children of parents with childhood onset of the disorder: a pilot study. (1995) (292)
- New insights into the comorbidity between ADHD and major depression in adolescent and young adult females. (2008) (284)
- Attention-deficit/hyperactivity disorder and comorbidity. (1999) (277)
- Effect of stimulants on height and weight: a review of the literature. (2008) (268)
- Dopamine D4 gene 7-repeat allele and attention deficit hyperactivity disorder. (1999) (259)
- Efficacy of a mixed amphetamine salts compound in adults with attention-deficit/hyperactivity disorder. (2001) (256)
- A Randomized, Placebo-Controlled Trial of OROS Methylphenidate in Adults with Attention-Deficit/Hyperactivity Disorder (2006) (249)
- Comparing the efficacy of medications for ADHD using meta-analysis. (2006) (249)
- Growth deficits in ADHD children revisited: evidence for disorder-associated growth delays? (1996) (241)
- A controlled clinical trial of bupropion for attention deficit hyperactivity disorder in adults. (2001) (238)
- Emotional Dysregulation in Adult ADHD and Response to Atomoxetine (2005) (233)
- Adult psychiatric outcomes of girls with attention deficit hyperactivity disorder: 11-year follow-up in a longitudinal case-control study. (2010) (231)
- Presenting ADHD symptoms, subtypes, and comorbid disorders in clinically referred adults with ADHD. (2009) (229)
- Evidence-based pharmacotherapy for attention-deficit hyperactivity disorder. (2004) (226)
- Six-week, double-blind, placebo-controlled study of desipramine for adult attention deficit hyperactivity disorder. (1996) (224)
- Presenting ADHD symptoms and subtypes in clinically referred adults with ADHD (1997) (220)
- Overview and neurobiology of attention-deficit/hyperactivity disorder. (2002) (218)
- A pilot controlled clinical trial of ABT-418, a cholinergic agonist, in the treatment of adults with attention deficit hyperactivity disorder. (1999) (218)
- ADHD and comorbidity in childhood. (2006) (215)
- Risperidone treatment for juvenile bipolar disorder: a retrospective chart review. (1999) (214)
- PET study examining pharmacokinetics, detection and likeability, and dopamine transporter receptor occupancy of short- and long-acting oral methylphenidate. (2006) (207)
- Functional magnetic resonance imaging of methylphenidate and placebo in attention-deficit/hyperactivity disorder during the multi-source interference task. (2008) (207)
- Understanding Attention-Deficit/Hyperactivity Disorder from Childhood to Adulthood (2010) (206)
- Atomoxetine treatment in children and adolescents with ADHD and comorbid tic disorders (2005) (203)
- Do Stimulants Protect Against Psychiatric Disorders in Youth With ADHD? A 10-Year Follow-up Study (2009) (201)
- A review of the pharmacotherapy of adults with Attention-Deficit/ Hyperactivity Disorder (2001) (191)
- Atomoxetine treatment in children and adolescents with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder. (2005) (186)
- Disentangling the overlap between Tourette's disorder and ADHD. (1998) (185)
- Adults with attention-deficit/hyperactivity disorder: a controversial diagnosis. (1998) (183)
- The World Health Organization Adult Attention-Deficit/Hyperactivity Disorder Self-Report Screening Scale for DSM-5 (2017) (181)
- The stimulants revisited. (2000) (174)
- Stimulant therapy and risk for subsequent substance use disorders in male adults with ADHD: a naturalistic controlled 10-year follow-up study. (2008) (174)
- Family study of girls with attention deficit hyperactivity disorder. (2000) (172)
- Clonidine for sleep disturbances associated with attention-deficit hyperactivity disorder: a systematic chart review of 62 cases. (1996) (167)
- Atomoxetine and methylphenidate treatment in children with ADHD: a prospective, randomized, open-label trial. (2002) (166)
- Stability of executive function deficits into young adult years: a prospective longitudinal follow‐up study of grown up males with ADHD (2007) (165)
- Psychopathology in Females with Attention-Deficit/Hyperactivity Disorder: A Controlled, Five-Year Prospective Study (2006) (163)
- Heterogeneity of Irritability in Attention-Deficit/Hyperactivity Disorder Subjects With and Without Mood Disorders (2005) (161)
- The naturalistic course of pharmacologic treatment of children with maniclike symptoms: a systematic chart review. (1998) (158)
- Gray Matter Alterations in Adults with Attention-Deficit/Hyperactivity Disorder Identified by Voxel Based Morphometry (2011) (158)
- Mixed Amphetamine Salts Extended-Release in the Treatment of Adult ADHD: A Randomized, Controlled Trial (2006) (155)
- Efficacy and Safety of Dexmethylphenidate Extended-Release Capsules in Adults with Attention-Deficit/Hyperactivity Disorder (2007) (154)
- Cardiovascular effects of therapeutic doses of tricyclic antidepressants in children and adolescents. (1996) (152)
- Long-term, open-label study of the safety and efficacy of atomoxetine in adults with attention-deficit/hyperactivity disorder: an interim analysis. (2005) (147)
- Relapse prevention in pediatric patients with ADHD treated with atomoxetine: a randomized, double-blind, placebo-controlled study. (2004) (143)
- Substance use among ADHD adults: implications of late onset and subthreshold diagnoses. (2007) (142)
- Pharmacotherapy of attention deficit hyperactivity disorder. (2000) (141)
- Further Evidence of Dopamine Transporter Dysregulation in ADHD: A Controlled PET Imaging Study Using Altropane (2007) (140)
- An open-label, dose-ranging study of atomoxetine in children with attention deficit hyperactivity disorder. (2001) (140)
- Pharmacotherapy of adult attention deficit/hyperactivity disorder: a review. (1995) (139)
- Blood pressure changes associated with medication treatment of adults with attention-deficit/hyperactivity disorder. (2005) (135)
- Once-Daily Atomoxetine for Adult Attention-Deficit/Hyperactivity Disorder: A 6-Month, Double-Blind Trial (2009) (134)
- A Laboratory School Comparison of Mixed Amphetamine Salts Extended Release (Adderall XR®) and Atomoxetine (Strattera®) in School-Aged Children With Attention Deficit/Hyperactivity Disorder (2005) (132)
- Is Attention‐Deficit Hyperactivity Disorder in Adults a Valid Disorder? (1994) (132)
- Risk for substance use disorders in youths with child- and adolescent-onset bipolar disorder. (1999) (130)
- Attention-deficit/hyperactivity disorder in adults: a survey of current practice in psychiatry and primary care. (2004) (123)
- Deficient emotional self-regulation and adult attention deficit hyperactivity disorder: a family risk analysis. (2011) (122)
- Pediatric mania: a developmental subtype of bipolar disorder? (2000) (120)
- Does prolonged therapy with a long-acting stimulant suppress growth in children with ADHD? (2006) (119)
- ADHD treatment with once-daily OROS methylphenidate: final results from a long-term open-label study. (2005) (118)
- Effect of psychostimulants on brain structure and function in ADHD: a qualitative literature review of magnetic resonance imaging-based neuroimaging studies. (2013) (118)
- Growth deficits and attention-deficit/hyperactivity disorder revisited: impact of gender, development, and treatment. (2003) (117)
- Functional effects of dopamine transporter gene genotypes on in vivo dopamine transporter functioning: a meta-analysis (2014) (116)
- Analog classroom assessment of a once-daily mixed amphetamine formulation, SLI381 (Adderall XR), in children with ADHD. (2003) (112)
- Understanding deficient emotional self-regulation in adults with attention deficit hyperactivity disorder: a controlled study (2013) (112)
- Systematic chart review of the pharmacologic treatment of comorbid attention deficit hyperactivity disorder in youth with bipolar disorder. (1999) (109)
- A naturalistic 10-year prospective study of height and weight in children with attention-deficit hyperactivity disorder grown up: sex and treatment effects. (2010) (109)
- The Reliability and Validity of Self- and Investigator Ratings of ADHD in Adults (2008) (105)
- A systematic chart review of the nature of psychiatric adverse events in children and adolescents treated with selective serotonin reuptake inhibitors. (2003) (105)
- Efficacy of atomoxetine in adult attention-Deficit/Hyperactivity Disorder: a drug-placebo response curve analysis (2005) (104)
- Clinical characteristics of psychiatrically referred adolescent outpatients with substance use disorder. (1997) (104)
- Toward Defining Deficient Emotional Self-Regulation in Children with Attention-Deficit/Hyperactivity Disorder Using the Child Behavior Checklist: A Controlled Study (2011) (104)
- Antecedents and complications of trauma in boys with ADHD: findings from a longitudinal study. (1999) (103)
- A double-blind comparison of desipramine and placebo in children and adolescents with chronic tic disorder and comorbid attention-deficit/hyperactivity disorder. (2002) (103)
- Cognitive Therapy in the Treatment of Adults With ADHD: A Systematic Chart Review of 26 Cases (1999) (102)
- Patterns of Psychopathology and Dysfunction in Clinically Referred Preschoolers (2002) (102)
- Long-term tolerability and effectiveness of once-daily mixed amphetamine salts (Adderall XR) in children with ADHD. (2005) (101)
- Neural Substrates of Impaired Sensorimotor Timing in Adult Attention-Deficit/Hyperactivity Disorder (2010) (101)
- Combining methylphenidate and clonidine: a clinically sound medication option. (1999) (99)
- Longitudinal course of deficient emotional self-regulation CBCL profile in youth with ADHD: prospective controlled study (2012) (98)
- Severity of the Aggression/Anxiety-Depression/Attention Child Behavior Checklist Profile Discriminates Between Different Levels of Deficits in Emotional Regulation in Youth With Attention-Deficit Hyperactivity Disorder (2012) (98)
- Efficacy and Safety of OROS Methylphenidate in Adults With Attention-Deficit/Hyperactivity Disorder: A Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Dose-Escalation Study (2009) (97)
- Atomoxetine pharmacokinetics in children and adolescents with attention deficit hyperactivity disorder. (2003) (97)
- Clonidine for sleep disturbances associated with attention-deficit hyperactivity disorder. (1994) (97)
- Therapeutic dilemmas in the pharmacotherapy of bipolar depression in the young. (2000) (97)
- Prenatal Nicotine Exposure Mouse Model Showing Hyperactivity, Reduced Cingulate Cortex Volume, Reduced Dopamine Turnover, and Responsiveness to Oral Methylphenidate Treatment (2012) (96)
- Effect of comorbid symptoms of oppositional defiant disorder on responses to atomoxetine in children with ADHD: a meta-analysis of controlled clinical trial data (2006) (96)
- Adult Outcome of ADHD: An Overview of Results From the MGH Longitudinal Family Studies of Pediatrically and Psychiatrically Referred Youth With and Without ADHD of Both Sexes (2018) (95)
- Growth deficits in children with attention deficit hyperactivity disorder. (1998) (95)
- Efficacy and safety of atomoxetine in adolescents with attention-deficit/hyperactivity disorder and major depression. (2007) (94)
- Comparison of clonidine response in the treatment of attention-deficit hyperactivity disorder with and without comorbid tic disorders. (1993) (93)
- Combined pharmacotherapy: an emerging trend in pediatric psychopharmacology. (1995) (93)
- The 4-year course of tic disorders in boys with attention-deficit/hyperactivity disorder. (1999) (93)
- Cerebellar Vermis Involvement in Cocaine-Related Behaviors (2006) (92)
- Stimulants and Sudden Death: What Is a Physician to Do? (2006) (92)
- Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study. (2006) (91)
- Pilot study of behavioral and emotional disturbances in the high-risk children of parents with opioid dependence. (1995) (91)
- Desipramine treatment of children with attention-deficit hyperactivity disorder and tic disorder or Tourette's syndrome. (1993) (90)
- Safety and effectiveness of coadministration of guanfacine extended release and psychostimulants in children and adolescents with attention-deficit/hyperactivity disorder. (2009) (89)
- Novel treatments for attention-deficit/hyperactivity disorder in children. (2002) (89)
- An open-label trial of risperidone in children and adolescents with bipolar disorder. (2005) (89)
- Comorbidity of attention-deficit hyperactivity and psychoactive substance use disorders. (1994) (89)
- Long-Term, Open-Label Safety and Efficacy of Atomoxetine in Adults With ADHD (2008) (88)
- Assessing the Validity of the Quality of Life Enjoyment and Satisfaction Questionnaire—Short Form in Adults With ADHD (2008) (88)
- A controlled study of nortriptyline in children and adolescents with attention deficit hyperactivity disorder. (2000) (87)
- Atomoxetine and adult attention-deficit/hyperactivity disorder: the effects of comorbidity. (2006) (87)
- Impact of tic disorders on ADHD outcome across the life cycle: findings from a large group of adults with and without ADHD. (2001) (86)
- Attention-deficit/hyperactivity disorder in children and adolescents with obsessive-compulsive disorder: fact or artifact? (2002) (86)
- Aripiprazole in the Treatment of Pediatric Bipolar Disorder: A Systematic Chart Review (2005) (85)
- Brain differences between persistent and remitted attention deficit hyperactivity disorder. (2014) (84)
- Short- and long-term cardiovascular effects of mixed amphetamine salts extended release in children. (2005) (83)
- Efficacy and safety of mixed amphetamine salts extended release (adderall XR) in the management of oppositional defiant disorder with or without comorbid attention-deficit/hyperactivity disorder in school-aged children and adolescents: A 4-week, multicenter, randomized, double-blind, parallel-group, (2006) (83)
- A Randomized, Double-Blind Study of Continuation Treatment for Attention-Deficit/Hyperactivity Disorder After 1 Year (2007) (83)
- Attention-deficit/hyperactivity disorder: diagnosis, lifespan, comorbidities, and neurobiology. (2007) (82)
- Guidelines and algorithms for the use of methylphenidate in children with Attention-Deficit/Hyperactivity Disorder (2002) (81)
- Stability of Executive Function Deficits in Girls with ADHD: A Prospective Longitudinal Followup Study into Adolescence (2007) (81)
- Validation of the Adult ADHD Investigator Symptom Rating Scale (AISRS) (2010) (81)
- Functional Outcomes in the Treatment of Adults With ADHD (2008) (81)
- Long-term effects of extended-release mixed amphetamine salts treatment of attention- deficit/hyperactivity disorder on growth. (2005) (80)
- Patterns of comorbidity and dysfunction in clinically referred preschool and school-age children with bipolar disorder. (2003) (77)
- Nicotine exposure of male mice produces behavioral impairment in multiple generations of descendants (2018) (76)
- The relationship between tic disorders and Tourette's syndrome revisited. (1995) (76)
- Preliminary examination of the reliability and concurrent validity of the attention-deficit/hyperactivity disorder self-report scale v1.1 symptom checklist to rate symptoms of attention-deficit/hyperactivity disorder in adolescents. (2012) (76)
- An open trial of bupropion for the treatment of adults with attention-deficit/hyperactivity disorder and bipolar disorder (2003) (76)
- Pharmacokinetics of SLI381 (ADDERALL XR), an extended-release formulation of Adderall. (2003) (75)
- Triple-bead mixed amphetamine salts (SPD465), a novel, enhanced extended-release amphetamine formulation for the treatment of adults with ADHD: a randomized, double-blind, multicenter, placebo-controlled study. (2008) (74)
- Controlled trial of high doses of pemoline for adults with attention-deficit/hyperactivity disorder. (1999) (73)
- The structure of adult ADHD (2017) (73)
- Atomoxetine and stroop task performance in adult attention-deficit/hyperactivity disorder. (2005) (73)
- Long-Term Safety and Effectiveness of Mixed Amphetamine Salts Extended Release in Adults With ADHD (2005) (72)
- Parsing pediatric bipolar disorder from its associated comorbidity with the disruptive behavior disorders (2001) (72)
- Reexamining Tic Persistence and Tic-Associated Impairment in Tourette's Disorder: Findings From a Naturalistic Follow-Up Study (2004) (72)
- A Randomized, 3-Phase, 34-Week, Double-Blind, Long-Term Efficacy Study of Osmotic-Release Oral System-Methylphenidate in Adults With Attention-Deficit/Hyperactivity Disorder (2010) (72)
- Tourette disorder and ADHD. (2001) (71)
- Transgenerational Transmission of Hyperactivity in a Mouse Model of ADHD (2014) (71)
- Atomoxetine treatment in children and adolescents with attention-deficit hyperactivity disorder: what are the long-term health-related quality-of-life outcomes? (2006) (70)
- A systematic assessment of tricyclic antidepressants in the treatment of adult attention-deficit hyperactivity disorder. (1995) (70)
- An Open-Label Trial of Aripiprazole Monotherapy in Children and Adolescents with Bipolar Disorder (2007) (70)
- Similarities in response to fluoxetine in the treatment of children and adolescents with obsessive-compulsive disorder. (1995) (70)
- Mild Traumatic Brain Injury and ADHD (2014) (69)
- A family study of psychiatric comorbidity in girls and boys with attention-deficit/hyperactivity disorder (2001) (69)
- The clinical characteristics of unipolar vs. bipolar major depression in ADHD youth. (2004) (68)
- Nonstimulant treatment of adult attention-deficit/hyperactivity disorder. (2004) (68)
- Deficient emotional self-regulation and pediatric attention deficit hyperactivity disorder: a family risk analysis (2011) (67)
- Effects of atomoxetine on growth in children with attention-deficit/hyperactivity disorder following up to five years of treatment. (2007) (66)
- Nortriptyline in the treatment of ADHD: a chart review of 58 cases. (1993) (65)
- Long-Term Cardiovascular Effects of Mixed Amphetamine Salts Extended Release in Adults With ADHD (2005) (65)
- Conceptualization and Assessment of Quality of Life for Adults with Attention- Deficit/Hyperactivity Disorder (2005) (65)
- A family study of the high-risk children of opioid- and alcohol-dependent parents. (2002) (65)
- Mild Traumatic Brain Injury and Attention-Deficit Hyperactivity Disorder in Young Student Athletes (2015) (64)
- The Relationship Between Executive Function Deficits and DSM-5-Defined ADHD Symptoms (2018) (62)
- Attention-Deficit/Hyperactivity Disorder and Adverse Health Outcomes in Adults (2014) (62)
- PSYCHIATRIC DIAGNOSIS IN PRESCHOOL CHILDREN (2003) (61)
- Effects of Atomoxetine on Growth After 2-Year Treatment Among Pediatric Patients With Attention-Deficit/Hyperactivity Disorder (2005) (60)
- Emergence of tics in children with ADHD: impact of once-daily OROS methylphenidate therapy. (2004) (60)
- Safety and tolerability of atomoxetine over 3 to 4 years in children and adolescents with ADHD. (2009) (60)
- Current concepts in the validity, diagnosis and treatment of paediatric bipolar disorder. (2003) (59)
- Changes in Symptoms and Adverse Events After Discontinuation of Atomoxetine in Children and Adults With Attention Deficit/Hyperactivity Disorder: A Prospective, Placebo-Controlled Assessment (2004) (58)
- Functional Genomics of Attention-Deficit/Hyperactivity Disorder (ADHD) Risk Alleles on Dopamine Transporter Binding in ADHD and Healthy Control Subjects (2013) (57)
- Distinguishing illness severity from tic severity in children and adolescents with Tourette's disorder. (2000) (57)
- A prospective open-label treatment trial of ziprasidone monotherapy in children and adolescents with bipolar disorder. (2007) (56)
- Atomoxetine Treatment of ADHD in Children With Comorbid Tourette Syndrome (2008) (55)
- Are stimulants effective in the treatment of executive function deficits? Results from a randomized double blind study of OROS-methylphenidate in adults with ADHD (2011) (55)
- Case Study: Bupropion Exacerbates Tics in Children with Attention-deficit Hyperactivity Disorder and Tourette's Syndrome (1993) (54)
- A laboratory driving simulation for assessment of driving behavior in adults with ADHD: a controlled study (2007) (54)
- Relationship of DAT1 and adult ADHD to task-positive and task-negative working memory networks (2011) (53)
- Examining the nature of the comorbidity between pediatric attention deficit/hyperactivity disorder and post‐traumatic stress disorder (2013) (53)
- Plasma and brain concentrations of oral therapeutic doses of methylphenidate and their impact on brain monoamine content in mice (2009) (53)
- Temporal association between childhood psychopathology and substance use disorders: findings from a sample of adults with opioid or alcohol dependency (2002) (52)
- The Course of Tourette's Disorder: A Literature Review (2000) (52)
- Examining the association between posttraumatic stress disorder and attention-deficit/hyperactivity disorder: a systematic review and meta-analysis. (2016) (51)
- Case study: adverse effects of smoking marijuana while receiving tricyclic antidepressants. (1997) (51)
- ADHD treatment across the life cycle. (2004) (51)
- Absence of association with DAT1 polymorphism and response to methylphenidate in a sample of adults with ADHD (2006) (51)
- Training Raters to Assess Adult ADHD: Reliability of Ratings (2005) (51)
- Representativeness of participants in a clinical trial for attention-deficit/hyperactivity disorder? Comparison with adults from a large observational study. (2010) (49)
- Effect of dopamine transporter gene (SLC6A3) variation on dorsal anterior cingulate function in attention‐deficit/hyperactivity disorder (2010) (48)
- A preliminary study of dopamine D4 receptor genotype and structural brain alterations in adults with ADHD (2008) (48)
- Stimulant treatment of adult attention-deficit/hyperactivity disorder. (2004) (46)
- Pharmacotherapy of Attention Deficit Hyperactivity Disorder in Adults (1998) (46)
- Adjunctive donepezil in attention deficit hyperactivity disorder youth: case series. (2000) (45)
- Dissociation of working memory impairments and attention-deficit/hyperactivity disorder in the brain (2015) (45)
- Attention and working memory deficits in a perinatal nicotine exposure mouse model (2018) (44)
- Cardiovascular effects of longer-term, high-dose OROS methylphenidate in adolescents with attention deficit hyperactivity disorder. (2009) (44)
- Treatment of ADHD with stimulant medications: response to Nissen perspective in the New England Journal of Medicine. (2006) (43)
- Do stimulants reduce the risk for cigarette smoking in youth with attention-deficit hyperactivity disorder? A prospective, long-term, open-label study of extended-release methylphenidate. (2013) (43)
- Psychopharmacological interventions. (2008) (43)
- Toward Defining the Neural Substrates of ADHD (2015) (43)
- ADHD and thyroid abnormalities: a research note. (1995) (43)
- A randomized, placebo-controlled clinical trial of bupropion for the prevention of smoking in children and adolescents with attention-deficit/hyperactivity disorder. (2007) (42)
- Attention-Deficit Hyperactivity Disorder and the Psychoactive Substance Use Disorders (1996) (41)
- Family based association study of pediatric bipolar disorder and the dopamine transporter gene (SLC6A3) (2008) (41)
- Effect of candidate gene polymorphisms on the course of attention deficit hyperactivity disorder (2009) (39)
- Is ADHD a risk for posttraumatic stress disorder (PTSD)? Results from a large longitudinal study of referred children with and without ADHD (2014) (39)
- An open-label study of the tolerability of mixed amphetamine salts in adults with attention-deficit/hyperactivity disorder and treated primary essential hypertension. (2006) (39)
- A prenatal nicotine exposure mouse model of methylphenidate responsive ADHD-associated cognitive phenotypes (2017) (38)
- A post hoc subgroup analysis of an 18-day randomized controlled trial comparing the tolerability and efficacy of mixed amphetamine salts extended release and atomoxetine in school-age girls with attention-deficit/hyperactivity disorder. (2006) (38)
- An Open-Label Trial of OROS Methylphenidate in Adults with Late-Onset ADHD (2006) (38)
- Comparative acute efficacy and tolerability of OROS and immediate release formulations of methylphenidate in the treatment of adults with attention-deficit/hyperactivity disorder (2007) (37)
- Memantine in the Treatment of Executive Function Deficits in Adults With ADHD (2017) (37)
- Methylphenidate and μ opioid receptor interactions: A pharmacological target for prevention of stimulant abuse (2011) (37)
- Posttraumatic stress disorder in adult attention-deficit/hyperactivity disorder: clinical features and familial transmission. (2013) (36)
- Methylphenidate in treatment of adults with Attention-Deficit/Hyperactivity Disorder (2002) (36)
- Genetics of childhood disorders: XIX. ADHD, Part 3: Is ADHD a noradrenergic disorder? (2000) (36)
- Non-stimulant treatments for ADHD (2009) (34)
- A pilot open label prospective study of memantine monotherapy in adults with ADHD (2013) (34)
- Absence of cardiovascular adverse effects of sertraline in children and adolescents. (1999) (34)
- Telemedicine in the Management of ADHD: Literature Review of Telemedicine in ADHD (2020) (34)
- Further evidence that severe scores in the aggression/anxiety-depression/attention subscales of child behavior checklist (severe dysregulation profile) can screen for bipolar disorder symptomatology: a conditional probability analysis. (2014) (34)
- Attention-deficit/hyperactivity disorder-specific quality of life with triple-bead mixed amphetamine salts (SPD465) in adults: results of a randomized, double-blind, placebo-controlled study. (2008) (33)
- Effects of lisdexamfetamine dimesylate treatment for ADHD on growth. (2010) (33)
- Pemoline treatment of adolescents with attention deficit hyperactivity disorder: a short-term controlled trial. (2000) (32)
- Attention-deficit hyperactivity disorder and comorbid substance use disorders in adults. (1995) (32)
- New developments in the treatment of ADHD. (2006) (32)
- Comparison of Parent and Teacher Reports of Attention-Deficit/Hyperactivity Disorder Symptoms from Two Placebo-Controlled Studies of Atomoxetine in Children (2006) (32)
- Non-stimulant treatment for Attention-Deficit/Hyperactivity Disorder (2002) (32)
- Growth deficits in children treated with desipramine: a controlled study. (1992) (31)
- Neuropsychological Deficits Are Not Predictive of Deficient Emotional Self-Regulation in Adults With ADHD (2015) (30)
- Is bipolar disorder a risk for cigarette smoking in ADHD youth? (2000) (28)
- A Randomized, Single-Blind, Substitution Study of OROS Methylphenidate (Concerta) in ADHD Adults Receiving Immediate Release Methylphenidate (2011) (28)
- Personal and familial correlates of bipolar (BP)-I disorder in children with a diagnosis of BP-I disorder with a positive child behavior checklist (CBCL)-severe dysregulation profile: a controlled study. (2013) (27)
- Case study: nefazodone for juvenile mood disorders. (1997) (27)
- Donepezil in the Treatment of ADHD-Like Symptoms in Youths With Pervasive Developmental Disorder (2006) (26)
- Attention-deficit hyperactivity disorder in adults and children (2015) (26)
- Atomoxetine treatment of ADHD in children with comorbid Tourette syndrome. (2008) (26)
- Nortriptyline treatment of children with attention-deficit hyperactivity disorder and tic disorder or Tourette's syndrome. (1993) (24)
- Are Attention‐Deficit Hyperactivity Disorder and the Psychoactive Substance Use Disorders Really Related? (1995) (24)
- Short- and Long-Term Cardiovascular Effects of Mixed Amphetamine Salts Extended-Release in Adolescents With ADHD (2005) (24)
- Validation of the Expanded Versions of the Adult ADHD Self-Report Scale v1.1 Symptom Checklist and the Adult ADHD Investigator Symptom Rating Scale (2019) (23)
- Bupropion exacerbates tics in children with attention-deficit hyperactivity disorder and Tourette's syndrome. (1993) (23)
- A retrospective study of serum levels and electrocardiographic effects of nortriptyline in children and adolescents. (1993) (23)
- An open trial of adjunctive donepezil in attention-deficit/hyperactivity disorder. (2005) (23)
- Issues in the Management of Patients with Complex Attention-Deficit Hyperactivity Disorder Symptoms (2009) (22)
- Consensus Statement on ADHD (2002) (22)
- A Double-blind Comparison of Galantamine Hydrogen Bromide and Placebo in Adults With Attention-Deficit/Hyperactivity Disorder: A Pilot Study (2006) (22)
- The course and outcome of attention-deficit/hyperactivity disorder. (2004) (22)
- Is Maternal Smoking During Pregnancy a Risk Factor for Cigarette Smoking in Offspring? A Longitudinal Controlled Study of ADHD Children Grown Up (2017) (21)
- A naturalistic assessment of protriptyline for attention-deficit hyperactivity disorder. (1996) (21)
- Efficacy and safety of dexmethylphenidate extended-release capsules administered once daily to children with attention-deficit/hyperactivity disorder. (2009) (20)
- A PET study examining pharmacokinetics and dopamine transporter occupancy of two long-acting formulations of methylphenidate in adults. (2009) (20)
- The Neuropsychological Profile of Comorbid Post-Traumatic Stress Disorder in Adult ADHD (2016) (20)
- Adaptive changes related to medication treatment of ADHD: listening to parents of children in clinical trials of a novel nonstimulant medication. (2002) (20)
- Dasotraline in Children with Attention-Deficit/Hyperactivity Disorder: A Six-Week, Placebo-Controlled, Fixed-Dose Trial. (2019) (19)
- Informativeness of structured diagnostic interviews in the identification of Tourette's disorder in referred youth. (2000) (19)
- Risperidone for the treatment of affective symptoms in children with disruptive behavior disorder: a post hoc analysis of data from a 6-week, multicenter, randomized, double-blind, parallel-arm study. (2006) (19)
- Further understanding of the comorbidity between attention-deficit/hyperactivity disorder and bipolar disorder in adults: An MRI study of cortical thickness (2012) (19)
- A Positron Emission Tomography Study Examining The Dopaminergic Activity of Armodafinil in Adults Using [11C]Altropane and [11C]Raclopride (2010) (19)
- Absence of Effect of Stimulants on the Pharmacokinetics of Desipramine in Children (1999) (19)
- Is Paternal Smoking at Conception a Risk for ADHD? A Controlled Study in Youth With and Without ADHD (2020) (18)
- The drug-placebo response curve: a new method for assessing drug effects in clinical trials. (2000) (18)
- Is Response to OROS‐Methylphenidate Treatment Moderated by Treatment with Antidepressants or Psychiatric Comorbidity? A Secondary Analysis from a Large Randomized Double Blind Study of Adults with ADHD (2012) (17)
- Sport concussion and attention deficit hyperactivity disorder in student athletes: A cohort study (2018) (16)
- Efficacy and Tolerability of Long-Term, Open-Label, Mixed Amphetamine Salts Extended Release in Adolescents With ADHD (2005) (16)
- Abnormal fear circuitry in Attention Deficit Hyperactivity Disorder: A controlled magnetic resonance imaging study (2017) (16)
- Desipramine clearance in children and adolescents: absence of effect of development and gender. (1999) (16)
- How Informative Are Self-Reported Adult Attention-Deficit/Hyperactivity Disorder Symptoms? An Examination of the Agreement Between the Adult Attention-Deficit/Hyperactivity Disorder Self-Report Scale V1.1 and Adult Attention-Deficit/Hyperactivity Disorder Investigator Symptom Rating Scale. (2017) (16)
- Pharmacology of Amphetamines (1998) (15)
- Venlafaxine for adult ADHD. (1995) (15)
- Juvenile mood disorders and office psychopharmacology. (1997) (15)
- Toward operationalizing deficient emotional self-regulation in newly referred adults with ADHD: A receiver operator characteristic curve analysis (2020) (15)
- Depressive disorders in childhood and adolescence: a clinical perspective. (1999) (14)
- Neurobiology and Genetics of ADHD in Adults (2008) (14)
- Dopamine-transporter density in patients with ADHD (2000) (14)
- Adult ADHD Investigator Symptom Rating Scale (2012) (13)
- Utility of an abbreviated questionnaire to identify individuals with ADHD at risk for functional impairments. (2008) (12)
- Disentangling disinhibition. (1998) (12)
- Atomoxetine in the treatment of children with ADHD: A randomized, placebo-controlled dose-response study (2001) (12)
- Psychotropic Medication for Children And Adolescents (1995) (12)
- Examination of concordance between maternal and youth reports in the diagnosis of pediatric bipolar disorder. (2009) (12)
- Predicting desipramine levels in children and adolescents: a naturalistic clinical study. (1997) (11)
- Psychiatric diagnosis in preschool children. Authors' replies (2003) (11)
- Tricyclic antidepressant treatment of children with ADHD and tic disorders. (1994) (10)
- Toward a New Understanding of Attention-Deficit Hyperactivity Disorder (2009) (10)
- Towards operationalising internal distractibility (Mind Wandering) in adults with ADHD (2017) (10)
- Acceptability of an adjunct equine-assisted activities and therapies program for veterans with posttraumatic stress disorder and/or traumatic brain injury. (2020) (9)
- A General Framework for Assessing In vitro/In vivo Correlation as a Tool for Maximizing the Benefit‐Risk Ratio of a Treatment Using a Convolution‐Based Modeling Approach (2019) (9)
- Best practices in adult ADHD (2008) (9)
- Dose Response Effects of Lisdexamfetamine Dimesylate Treatment in Adults With ADHD (2012) (9)
- Importance of Pharmacokinetic Profile and Timing of Coadministration of Short– and Long–Acting Formulations of Methylphenidate on Patterns of Subjective Responses and Abuse Potential (2012) (8)
- ADHD and comorbidity (2006) (8)
- Transgenerational transmission of behavioral phenotypes produced by exposure of male mice to saccharin and nicotine (2020) (8)
- The Rights of Children and Parents In Regard to Children Receiving Psychiatric Diagnoses and Drugs (2014) (8)
- Frontal Cortical Monoamine Release, Attention, and Working Memory in a Perinatal Nicotine Exposure Mouse Model Following Kappa Opioid Receptor Antagonism. (2020) (8)
- Opiate Antagonists Do Not Interfere With the Clinical Benefits of Stimulants in ADHD: A Double-Blind, Placebo-Controlled Trial of the Mixed Opioid Receptor Antagonist Naltrexone. (2017) (8)
- Attention deficit hyperactivity disorder and affective disorders in childhood: continuum, comorbidity or confusion (2000) (7)
- Reliability and validity of the Time-Sensitive ADHD Symptom Scale in adults. (2011) (7)
- Comparative effectiveness of prolonged exposure and cognitive processing therapy for military service members in an intensive treatment program. (2020) (7)
- Understanding the central pharmacokinetics of spheroidal oral drug absorption system (SODAS) dexmethylphenidate: a positron emission tomography study of dopamine transporter receptor occupancy measured with C-11 altropane. (2012) (7)
- Collaborative Songwriting Intervention for Veterans with Post-traumatic Stress Disorder. (2020) (6)
- Pharmacology of Adult ADHD with Stimulants (2007) (6)
- Assessment and Treatment of Attention-Deficit Hyperactivity Disorder (2010) (6)
- A Familial Risk Analysis of Emotional Dysregulation: A Controlled Study (2018) (6)
- Short-Term Cardiovascular Effects of Mixed Amphetamine Salts Extended Release in Children and Adolescents With Oppositional Defiant Disorder (2005) (6)
- The Mixed Opioid Receptor Antagonist Naltrexone Mitigates Stimulant-Induced Euphoria: A Double-Blind, Placebo-Controlled Trial of Naltrexone. (2018) (6)
- Striatal dopamine transporter binding in adults with ADHD. (2012) (6)
- Effect of atomoxetine on Tanner stage sexual development in children and adolescents with attention deficit/hyperactivity disorder: 18-month results from a double-blind, placebo-controlled trial (2011) (5)
- EVIDENCE OF A PHARMACOLOGICAL DISSOCIATION BETWEEN THE ROBUST EFFECTS OF METHYLPHENIDATE ON ADHD SYMPTOMS AND WEAKER EFFECTS ON WORKING MEMORY (2015) (5)
- Are Adult ADHD Patients Good Informants of Their Symptoms? A Qualitative Literature Review of Concordance Between Clinician and Self-Report ADHD Symptoms (2018) (5)
- Mixed Amphetamine Salts Extended Release for the Treatment of ADHD in Adolescents: Current Evidence (2005) (5)
- Academic Highlights: Managing ADHD in Children, Adolescents, and Adults With Comorbid Anxiety. [CME] (2007) (5)
- A Public Dual Diagnosis Detoxification Unit: Part II: Observations of 70 Dually Diagnosed Patients (1993) (4)
- P.6.076 Long-term treatment effects of atomoxetine in adults with attention-deficit/hyperactivity disorder (ADHD) (2003) (4)
- Safety of atomoxetine in pediatric patients treated for ADHD (2001) (4)
- Adult attention-deficit/hyperactivity disorder. (2004) (4)
- Long-term, open-label safety and efficacy of atomoxetine in adults with attention-deficit/hyperactivity disorder: final report of a 4-year study (2007) (4)
- Issues in the Management of Patients with Complex ADHD Symptoms (2009) (4)
- Preliminary Reliability and Validity of a New Time-Sensitive ADHD Symptom Scale in Adolescents with ADHD (2011) (4)
- The Epidemiology of Adult ADHD (2008) (4)
- Adult ADHD: Diversion and Misuse of Medications (2008) (4)
- Medications Used for Attention-Deficit/Hyperactivity Disorder (2009) (3)
- P.6.070 Atomoxetine in the long-term prevention of relapse in ADHD (2003) (3)
- RESPONDERS AND NONRESPONDERS Respond (1996) (3)
- Efficacy and safety of atomoxetine in the treatment of attention deficit/hyperactivity disorder in children and adolescents (2002) (3)
- Treatment of Adult ADHD and Comorbid Depression (2008) (3)
- Current Treatments of Attention-Deficit/Hyperactivity Disorder (2000) (3)
- Prenatal Nicotine Exposure Mouse Model of ADHD (2011) (3)
- An accelerated, weekend-based, prolonged exposure therapy program for veterans and service members with posttraumatic stress disorder (2021) (2)
- Tricyclic antidepressant treatment of hyperactivity (1994) (2)
- Sudden (un)explained death. (1997) (2)
- A pilot study of a mind-body stress management program for student veterans. (2020) (2)
- P.6.029 Efficacy in a 5 month trial of methylphenidate in adults with attention-deficit/hyperactivity disorder (2004) (2)
- Antidepressant treatment of juvenile depression. (1999) (2)
- Child and Adolescent Psychopharmacology (1998) (2)
- Attention-Deficit Hyperactivity Disorder (ADHD) and Thyroid Abnormalities (1994) (2)
- P.7.d.003 The validity of the quality of life enjoyment and satisfaction questionnaire in adults with ADHD (2006) (2)
- Continued atomoxetine in pediatric patients with attention-deficit/hyperactivity disorder after 1 year of treatment (2004) (2)
- Can pediatric bipolar-I disorder be diagnosed in the context of posttraumatic stress disorder? A familial risk analysis (2013) (2)
- ADHD: applying practice guidelines to improve patient outcome and executive function. (2006) (2)
- ADHD and tic disorders (2015) (2)
- Practical child and adolescent psychopharmacology: Attention-deficit/hyperactivity disorder (2002) (2)
- 6.16 Dasotraline in Children With Attention-Deficit/Hyperactivity Disorder (ADHD): Results of a Randomized, Double-Blind, Placebo-Controlled Study (2017) (2)
- EFFECT OF LONG-TERM TREATMENT WITH STIMULANT MEDICATION ON GROWTH? (2007) (1)
- 5.62 Validation of the Expanded Versions of the Adult ADHD Self-Report Scale (ASRS) v1.1 Symptom Checklist and the Adult ADHD Investigator Symptom Rating Scale (AISRS) (2017) (1)
- Pharmacologic Advances in the Treatment of ADHD (2002) (1)
- Informativeness of Self-Reports of ADHD Symptoms in Monitoring Response to Stimulant Treatment in Clinically Referred Adults With ADHD (2020) (1)
- The Value of Screening for Adults with ADHD (2001) (1)
- ADHD in Adults: Stimulant treatment of adult ADHD (2011) (1)
- P.8.a.021 Comparative acute efficacy and tolerability of OROS and immediate release formulations of methylphenidate in the treatment of adults with ADHD (2006) (1)
- ATOMOXETINE IN ADOLESCENTS WITH ADHD AND COMORBID DEPRESSION (2006) (1)
- P.7.c.005 Pharmacokinetics, detection, likeability and dislikeability of two formulations of long-acting oral methylphenidate (2006) (1)
- ATOMOXETINE AND PREGNANCY: Dr. Heiligenstein et al. reply (2003) (1)
- P.6.075 Effects of atomoxetine treatment on executive functioning in adults with attention-deficit/hyperactivity disorder (ADHD) (2003) (1)
- RESPONDERS AND NONRESPONDERS. AUTHORS' REPLY (1996) (1)
- Further Evidence of Dopamine Transporter Receptor Dysregulation in ADHD: A Controlled PET Imaging Study Using Altropane (2009) (0)
- A PET study examining dopamine transporter occupancy of repeat dosing of two formulations of methylphenidate in adults (2007) (0)
- Neuroimaging of ADHD (2015) (0)
- Time-Sensitive ADHD Symptom Scale (2016) (0)
- Stimulant Medications and Growth (2009) (0)
- A PET study examining the dopaminergic activity of armodafinil in healthy adults using PET with 11C Altropane and 11C Raclopride (2010) (0)
- Response to Selveraj et al. (2014) (0)
- Attention-deficit/hyperactivity disorder. (2002) (0)
- Effects of DAT gene polymorphisms and ADHD status on DAT binding measured with PET (2012) (0)
- Press 978-0-521-11398-4-Attention-Deficit Hyperactivity Disorder in Adults and Children (0)
- New Investigations on the Relationship Between Working Memory and Attention-Deficit/Hyperactivity Disorder (2016) (0)
- SUDDEN (UN)EXPLAINED DEATH. AUTHORS' REPLY (1997) (0)
- 24.0 New Investigations on the Relationship Between Working Memory and Attention-Deficit/Hyperactivity Disorder (2016) (0)
- JQ Bostic et a 1 ANTIDEPRESSANT TREATMENTS ANTIDEPRESSANTS (2007) (0)
- Attention-deficit/hyperactivity disorder treatment with a once-daily formulation of methylphenidate: Effect on growth and tics (2002) (0)
- In reply [4] (2006) (0)
- Clinical Updates in Neuropsychiatry NEWS FROM THE 17TH ANNUAL U.S. PSYCHIATRIC & MENTAL HEALTH CONGRESS MIXED AMPHETAMINE SALTS XR MAY IMPROVE ODD SYMPTOMS IN CHILDREN (2013) (0)
- Stimulants and Sudden Death: What Is the Real Risk?: In Reply (2007) (0)
- Stimulant medication in children and adolescents (2015) (0)
- 53-5 The relationship of juvenile psychiatric and substance use disorders (1997) (0)
- 10.2 Effect of an Opioid Receptor Antagonist on Stimulant Treatment of Adults With Attention-Deficit/Hyperactivity Disorder (2016) (0)
- Absence of Unfavorable Effect of Atomoxetine on Growth in Pediatric Patients Is Still Not Demonstrated: In Reply (2006) (0)
- Revisit to Radiomethylation of [11C]MeNER: Optimization and Improved automated loop radiosynthesis of PET radiopharmaceutical [11C]MeNER for norepinephrine transporters imaging (2018) (0)
- Time course of dopamine transporter (DAT) occupancy of a long-acting formulation of dexmethylphenidate (2008) (0)
- P.6.077 Long-term effects of atomoxetine on growth in children with APHD (2003) (0)
- Pharmacotherapy of Depression and ADHD (2012) (0)
- FROM CHILDHOOD TO ADOLESCENCE : DIAGNOSIS AND COMORBIDITY ISSUES (2002) (0)
- P.6.039 Atomoxetine treatment in children with attention-deficit/hyperactivity disorder and comorbid tic disorders (2004) (0)
- Bibliography FOR C HILD A ND A DOLESCENT P SYCHIATRY (2008) (0)
- Effect of long-term treatment with stimulant medication on growth? Authors' reply (2007) (0)
- Substance Use Disorder Pharmacotherapy of Attention-deficit / Hyperactivity Disorder Reduces Risk for (1999) (0)
- Quantitative mapping of extrastriatal dopamine transporters in normal human subjects (2007) (0)
- P.6.012 Effects of environmental conditioning on SKF 38393-induced grooming behavior and quinpirole-induced stereotyped behavior after long term dopaminergic antagonists treatment (2004) (0)
- 24.4 EVIDENCE OF A PHARMACOLOGICAL DISSOCIATION BETWEEN THE ROBUST EFFECTS OF METHYLPHENIDATE ON ATTENTION-DEFICIT/HYPERACTIVITY DISORDER SYMPTOMS AND WEAKER EFFECTS ON WORKING MEMORY (2016) (0)
- Impact of Long-Term Treatment with OROS Methylphenidate on Pubertal Development in Adolescents with ADHD (2014) (0)
- C.14.03 Recognizing and treating attention- deficit/hyperactivity disorder in adults: short- and long-term treatment outcomes (2007) (0)
- Prevention of Stimulant Induced Euphoria with an Opioid Receptor Antagonist (2014) (0)
- Medications for ADDs with comorbid mood disorders &/or substance abuse (1994) (0)
- Dopamine transporter (DAT) dysregulation in attention deficit hyperactivity disorder (ADHD): A controlled PET study using 11C Altropane (2006) (0)
- 179 Dasotraline in Children With Attention Deficit Hyperactivity Disorder: Results of a Randomized, Double-Blind, Placebo-Controlled Study (2018) (0)
- THE NEWEST ADHD AGENT: ITS PLACE IN THE THERAPEUTIC ARMAMENTARIUM (2003) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Thomas J. Spencer?
Thomas J. Spencer is affiliated with the following schools:
